stockrowMiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Return on invested capital
MiniMed Group, Inc.'s return on invested capital over the twelve months to 31 July 2026 was −1.61%, up 2.0 percentage points from fiscal 2026 (−3.58%). That is below the Medical Instruments & Supplies industry median of 0.13% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | −3.58% | (0.85) |
| FY2025 | −2.73% | (2.73) |
| FY2024 | 0.00% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NVST Envista Holdings Corporation compare | 13.6% |
| MMSI Merit Medical Systems, Inc. compare | 6.87% |
| STVN Stevanato Group S.p.A. compare | 6.71% |
| ATRC AtriCure, Inc. compare | 2.61% |
| ICUI ICU Medical, Inc. compare | 2.27% |
| BLCO Bausch + Lomb Corporation compare | 2.16% |
| TFX Teleflex Incorporated compare | 0.51% |
| MMED MiniMed Group, Inc. | −1.61% |
| PLSE Pulse Biosciences, Inc compare | −37.0% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement